DJIA 17,959.44 154.64 0.87%
NASDAQ 4,781.42 16.04 0.34%
S&P 500 2,078.54 7.89 0.38%
market minute promo

Gilead Sciences (NASDAQ: GILD)

92.90 -15.55 (-14.34%)

REAL-TIME: Last trade at

Extended Hours: $93.35 $0.45 (0.48%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

GILD $92.90 -14.34%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $96.73
Previous Close $108.45
Daily Range $92.45 - $98.07
52-Week Range $63.50 - $116.83
Market Cap $140.2B
P/E Ratio 19.23
Dividend (Yield) $0.00 (0.0%)
Volume 71,438,613
Average Daily Volume 15,457,931
Current FY EPS $7.91

Sector

Healthcare

Industry

Drugs

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary Rss Feed

Why Gilead Sciences Shares Tumbled Today

Gilead Sciences shares fell sharply on concerns that competition from AbbVie's hepatitis C drug puts its market share at risk.

Gilead/Ono Pharmaceutical Ink Deal for Blood Cancer Drug - Analyst Blog

Bulls Make New Record High Despite Biotech Blues

Today's financial recap and tomorrow's financial outlook.

Week Ahead Market Report: December 22, 2014

Express Scripts Knocks Gilead's Hepatitis C Drug in Favor of AbbVie

Why I Am Not Selling Gilead

A Victory For Express Scripts And AbbVie At The Expense Of Gilead Sciences, J&J And... Oh Yeah, Pati

A Victory For Express Scripts And AbbVie At The Expense Of Gilead Sciences, J&J And... Oh Yeah, Patients

Monday's ETF Movers: EEM, BBH

Mid-Day Losers From December 22: Gilead, Ocwen Financial And More

What the AbbVie and Express Script Deal Means for Gilead

See More GILD News...

GILD's Top Competitors

GILD $92.90 (-14.34%)
Current stock: GILD
AMGN $164.53 (-3.31%)
Current stock: AMGN
CELG $113.50 (-3.14%)
Current stock: CELG
$0.00 (0.00%)
Current stock: